Trial · NCT02619617
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1 Placebo - 1st AttacK | STARTED | Placebo s.c. | 28 | |
| Period 1 Placebo - 1st AttacK | STARTED | SOM230 1.5 mg s.c. | 0 | |
| Period 1 Placebo - 1st AttacK | Participants Included in PD Analysis | Placebo s.c. | 20 | |
| Period 1 Placebo - 1st AttacK | Participants Included in PD Analysis | SOM230 1.5 mg s.c. | 0 | |
| Period 1 Placebo - 1st AttacK | Participants in Safety Set for Period 1 | Placebo s.c. | 28 | |
| Period 1 Placebo - 1st AttacK | Participants in Safety Set for Period 1 | SOM230 1.5 mg s.c. | 0 | |
| Period 1 Placebo - 1st AttacK | COMPLETED | Placebo s.c. | 28 | |
| Period 1 Placebo - 1st AttacK | COMPLETED | SOM230 1.5 mg s.c. | 0 | |
| Period 1 Placebo - 1st AttacK | NOT COMPLETED | Placebo s.c. | 0 | |
| Period 1 Placebo - 1st AttacK | NOT COMPLETED | SOM230 1.5 mg s.c. | 0 | |
| Period 2 SOM230 - 2nd Attack | STARTED | Placebo s.c. | 0 | |
| Period 2 SOM230 - 2nd Attack | STARTED | SOM230 1.5 mg s.c. | 28 | |
| Period 2 SOM230 - 2nd Attack | Participants in Safety Set for Period 2 | Placebo s.c. | 0 | |
| Period 2 SOM230 - 2nd Attack | Participants in Safety Set for Period 2 | SOM230 1.5 mg s.c. | 28 | |
| Period 2 SOM230 - 2nd Attack | COMPLETED | Placebo s.c. | 0 | |
| Period 2 SOM230 - 2nd Attack | COMPLETED | SOM230 1.5 mg s.c. | 24 | |
| Period 2 SOM230 - 2nd Attack | NOT COMPLETED | Placebo s.c. | 0 | |
| Period 2 SOM230 - 2nd Attack | NOT COMPLETED | SOM230 1.5 mg s.c. | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02619617/flow